Pancreas Cancer
A Randomized Phase III Study of Gemcitabine in Combination with Radiation Therapy versus Gemcitabine Alone in Patients with Localized, Unresectable, Pancreatic Cancer. [ECOG 4201]
Principal Investigator:
Elyse Schneiderman, MD
Adventist Hinsdale Hospital
630-654-1790
Contact person: Jan Wilson, RN